✦ LIBER ✦

Reply to detection of minimal residual disease in blood and bone marrow in early stage breast cancer

✍ Scribed by Savitri Krishnamurthy; Anthony Lucci

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 92 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.26092

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of minimal residual disease in

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer

✍ Jang-Fang Kuo; Wea-Long Lin; Chih-Ping Han 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

Detection of minimal residual disease in

Detection of minimal residual disease in blood and bone marrow in early stage breast cancer

✍ Savitri Krishnamurthy; Massimo Cristofanilli; Balraj Singh; James Reuben; Hui Ga 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

Outcome prediction by molecular detectio

Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma

✍ Horibe, Keizo ;Fukuda, Minoru ;Miyajima, Yuji ;Matsumoto, Kimikazu ;Kondo, Masar 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB 👁 2 views

Background. We have determined whether sequential molecular detection of minimal residual disease (MRD) in bone marrow (BM) could predict the outcome of patients with advanced neuroblastoma (NB). Procedure. Bone marrow samples from 19 patients over 12 months of age with stage 4 neuroblastoma were se

Magnetic resonance imaging to detect bon

Magnetic resonance imaging to detect bone marrow metastases in the initial staging of small cell lung carcinoma and breast carcinoma

✍ Guenter Layer; Andreas Steudel; Heinrich Schüller; Gerhard van Kaick; Frank Grün 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Background: Bone marrow is a common site of metastases in patients with small cell lung carcinoma (sclc) and female breast carcinoma (fbc). metastatic bone marrow involvement is found in approximately 50% of sclc patients and up to 85% of fbc patients at autopsy. initial staging procedures detec

Increased sensitivity for detection of m

Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation

✍ Bjørn Naume; Elin Borgen; Jahn M. Nesland; Klaus Beiske; Esther Gilen; Anne Reno 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 161 KB 👁 2 views

Immunocytochemical detection (ICC) of isolated tumor cells in bone marrow (BM) is currently the most established method for monitoring early dissemination in epithelial cancer. However, the low sample size that can practically be analyzed restricts the sensitivity and reliability of the ICC method.

Assessment of highly angiogenic and diss

Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse

✍ Alexandra Giatromanolaki; Michael I. Koukourakis; Stelios Kakolyris; Dimitris Ma 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 118 KB 👁 1 views

## Abstract The assessment of tumor molecular features in combination with the detection of occult malignant cells may provide important clinical information, beyond the standard staging of breast cancer. Using a nested RT‐PCR technique, we assessed prospectively the presence of cytokeratin‐19 (CK1